TGS Investor Presentation at the 2025 EAGE Conference OSLO, Norway (3 June 2025) – TGS, a leading provider of energy data and intelligence, attends investor meetings at the EAGE industry conference today. The presentation the company is using includes one new slide (#8 in the presentation) showing booked positions for streamer and OBN for the next quarters. The presentation can be downloaded from or For more information, visit TGS.com or contact: Bård Stenberg VP IR & Communication Mobile: Attachment
Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2). Please read the full announcement in PDF. Attachment
The Europe HY Trade Book for May 2025 includes current trade recommendations drawn from our European HY coverage universe, along with relative-value scatter plots and tables by industry. We also discuss the US tariff situation and key related impacts.
AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; Target price of A$0.30 per share: Adding four low risk drill-ready shallow gas prospects to start drilling by YE25 – ADX has now matured 13 shallow gas prospects across the ADX-AT-I and ADX-AT-II licence areas in Austria. The play is proven, supported by historical discoveries within the basin. Nearby historical discoveries in the area have produced 220 bcf to date. The prospects benefit from AVO anomalies, enhanc...
TGS: Shares Received by the Board of Directors OSLO, Norway (21 May 2025) - In accordance with the resolution made by the Annual General Meeting of TGS held on 8 May 2025, the Directors have now received restricted shares in TGS as part of their compensation. The Chair of the Board received 4,000 shares and the other Directors 2,400 shares each. The Company has distributed the restricted shares to the Directors from its balance of treasury shares. Following the transfer of restricted shares to the Directors, TGS holds 141,117 of the issued shares as treasury shares. Attached to this releas...
Combining EVP roles of Human Health Biosolutions and Strategy & Integration As a next step on Novonesis’ integration journey, we combine the two EVP areas Human Health Biosolutions and Strategy & Integration. COPENHAGEN, Denmark – After successfully combining into one company, Novonesis is delivering strong results, progressing firmly on the integration, as well as realizing synergies across the company. As a next step on our integration journey, the EVP area of Strategy & Integration will combine with the Human Health Biosolutions sales area. Henrik Joerck Nielsen, currently Executive Vi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.